
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17267467
[patent_doc_number] => 11192878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Piperidine-2,6-dione derivative and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/609805
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 15752
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609805 | Piperidine-2,6-dione derivative and use thereof | May 10, 2018 | Issued |
Array
(
[id] => 16090283
[patent_doc_number] => 20200199128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => PYRAZOLE[1,5-A]PYRIMIDINE DERIVATIVES AS KINASE JAK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/609891
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609891
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609891 | Pyrazole[1,5-a] pyrimidine derivatives as kinase JAK inhibitors | May 9, 2018 | Issued |
Array
(
[id] => 15740531
[patent_doc_number] => 20200109153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/611538
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611538
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611538 | HETEROARYL COMPOUNDS THAT INHIBIT G12C MUTANT RAS PROTEINS | May 7, 2018 | Abandoned |
Array
(
[id] => 13399817
[patent_doc_number] => 20180251451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => INDOLIN-2-ONE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/971399
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/971399 | Indolin-2-one derivatives | May 3, 2018 | Issued |
Array
(
[id] => 17251082
[patent_doc_number] => 11186554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => Non-fused tricyclic compounds
[patent_app_type] => utility
[patent_app_number] => 16/609715
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 102426
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609715 | Non-fused tricyclic compounds | May 1, 2018 | Issued |
Array
(
[id] => 16141317
[patent_doc_number] => 10703719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Method for producing 5-hydroxypiperidine-2-carboxylic acid
[patent_app_type] => utility
[patent_app_number] => 15/965289
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20506
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965289
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/965289 | Method for producing 5-hydroxypiperidine-2-carboxylic acid | Apr 26, 2018 | Issued |
Array
(
[id] => 14664881
[patent_doc_number] => 10370330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Method for producing 5-hydroxypiperidine-2-carboxylic acid
[patent_app_type] => utility
[patent_app_number] => 15/965316
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20557
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15965316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/965316 | Method for producing 5-hydroxypiperidine-2-carboxylic acid | Apr 26, 2018 | Issued |
Array
(
[id] => 15893549
[patent_doc_number] => 20200146293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => 2-(HET)ARYL-SUBSTITUTED FUSED HETEROCYCLE DERIVATIVES AS PESTICIDES
[patent_app_type] => utility
[patent_app_number] => 16/609631
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609631
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609631 | 2-(het)aryl-substituted fused heterocycle derivatives as pesticides | Apr 24, 2018 | Issued |
Array
(
[id] => 16072115
[patent_doc_number] => 20200190044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => COMPOUNDS HAVING ANTIINFECTIVE, ANTITUMORAL AND ANTIFUNGAL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/608268
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608268 | Compounds having antiinfective, antitumoral and antifungal activity | Apr 24, 2018 | Issued |
Array
(
[id] => 15451107
[patent_doc_number] => 20200038377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => INHIBITION OF PROTEIN DISULFIDE-ISOMERASE A3
[patent_app_type] => utility
[patent_app_number] => 16/605978
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/605978 | Inhibition of protein disulfide-isomerase A3 | Apr 16, 2018 | Issued |
Array
(
[id] => 16870002
[patent_doc_number] => 20210163469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => SMALL MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/604737
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604737
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604737 | Small molecules | Apr 12, 2018 | Issued |
Array
(
[id] => 13342759
[patent_doc_number] => 20180222919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => N-ALKYL-2-PHENOXYETHANAMINES, THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 15/944334
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -115
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/944334 | N-alkyl-2-phenoxyethanamines, their preparation and use | Apr 2, 2018 | Issued |
Array
(
[id] => 15850457
[patent_doc_number] => 10640494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof
[patent_app_type] => utility
[patent_app_number] => 15/942345
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 29915
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15942345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/942345 | N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof | Mar 29, 2018 | Issued |
Array
(
[id] => 13476355
[patent_doc_number] => 20180289720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
[patent_app_type] => utility
[patent_app_number] => 15/938001
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938001 | Compounds that inhibit MCL-1 protein | Mar 27, 2018 | Issued |
Array
(
[id] => 17634964
[patent_doc_number] => 11345676
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds
[patent_app_type] => utility
[patent_app_number] => 16/497695
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34419
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 422
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497695
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497695 | Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compounds | Mar 22, 2018 | Issued |
Array
(
[id] => 16688271
[patent_doc_number] => 20210070747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => 2(1H)-QUINOLINONE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/496066
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 749
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496066
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496066 | 2(1H)-QUINOLINONE DERIVATIVE | Mar 22, 2018 | Abandoned |
Array
(
[id] => 15435153
[patent_doc_number] => 20200031760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => BUILDING BLOCKS FOR STAPLED PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/497299
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497299
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497299 | Building blocks for stapled peptides | Mar 22, 2018 | Issued |
Array
(
[id] => 13986237
[patent_doc_number] => 20190062276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
[patent_app_type] => utility
[patent_app_number] => 15/927426
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 144631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927426
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927426 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | Mar 20, 2018 | Abandoned |
Array
(
[id] => 13521927
[patent_doc_number] => 20180312506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS
[patent_app_type] => utility
[patent_app_number] => 15/927170
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927170
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927170 | 1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins | Mar 20, 2018 | Issued |
Array
(
[id] => 15649467
[patent_doc_number] => 20200087263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => 5-CARBOXAMIDE-2-THIOBARBITURIC ACIDS AND USE THEREOF AS MEDICAMENTS
[patent_app_type] => utility
[patent_app_number] => 16/494433
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494433
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494433 | 5-carboxamide-2-thiobarbituric acids and use thereof as medicaments | Mar 14, 2018 | Issued |